Exosomes in the pathogenesis and treatment of cancer-related cachexia
- PMID: 38689293
- PMCID: PMC11062016
- DOI: 10.1186/s12967-024-05201-y
Exosomes in the pathogenesis and treatment of cancer-related cachexia
Abstract
Cancer-related cachexia is a metabolic syndrome characterized by weight loss, adipose tissue decomposition, and progressive skeletal muscle atrophy. It is a major complication of many advanced cancers and seriously affects the quality of life and survival of cancer patients. However, the specific molecules that mediate cancer-related cachexia remain elusive, and the fundamental cellular and molecular mechanisms associated with muscle atrophy and lipidolysis in cancer patients still need to be investigated. Exosomes, a newly discovered class of small extracellular vesicles that facilitate intercellular communication, have a significant role in the onset and development of various cancers. Studies have shown that exosomes play a role in the onset and progression of cancer-related cachexia by transporting active molecules such as nucleic acids and proteins. This review aimed to provide an overview of exosome developments in cancer-induced skeletal muscle atrophy and adipose tissue degradation. More importantly, exosomes were shown to have potential as diagnostic markers or therapeutic strategies for cachexia and were prospected, providing novel strategies for the diagnosis and treatment of cancer-related cachexia.
Keywords: Cancer-related cachexia; Exosomes; Lipidolysis; Muscle atrophy; Non-coding RNAs.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188359. doi: 10.1016/j.bbcan.2020.188359. Epub 2020 Mar 25. Biochim Biophys Acta Rev Cancer. 2020. PMID: 32222610 Free PMC article. Review.
-
Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release.Skelet Muscle. 2021 Jul 6;11(1):17. doi: 10.1186/s13395-021-00274-5. Skelet Muscle. 2021. PMID: 34229732 Free PMC article.
-
Mechanisms of cancer cachexia and targeted therapeutic strategies.Biochim Biophys Acta Rev Cancer. 2024 Nov;1879(6):189208. doi: 10.1016/j.bbcan.2024.189208. Epub 2024 Nov 13. Biochim Biophys Acta Rev Cancer. 2024. PMID: 39542382 Review.
-
The Contribution of Tumor Derived Exosomes to Cancer Cachexia.Cells. 2023 Jan 12;12(2):292. doi: 10.3390/cells12020292. Cells. 2023. PMID: 36672227 Free PMC article. Review.
-
Deliberation on debilitating condition of cancer cachexia: Skeletal muscle wasting.Fundam Clin Pharmacol. 2023 Dec;37(6):1079-1091. doi: 10.1111/fcp.12931. Epub 2023 Jul 20. Fundam Clin Pharmacol. 2023. PMID: 37474262 Review.
Cited by
-
Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications.Mol Cancer. 2024 Sep 7;23(1):191. doi: 10.1186/s12943-024-02106-8. Mol Cancer. 2024. PMID: 39244548 Free PMC article. Review.
-
Mesenchymal stem cell-derived exosomes: an emerging therapeutic strategy for hepatic ischemia-reperfusion injury.Stem Cell Res Ther. 2025 Apr 14;16(1):178. doi: 10.1186/s13287-025-04302-9. Stem Cell Res Ther. 2025. PMID: 40229893 Free PMC article. Review.
-
Regulatory Roles of Exosomes in Aging and Aging-Related Diseases.Biogerontology. 2025 Feb 18;26(2):61. doi: 10.1007/s10522-025-10200-7. Biogerontology. 2025. PMID: 39966192 Review.
-
Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases.Front Oncol. 2025 Mar 10;15:1534862. doi: 10.3389/fonc.2025.1534862. eCollection 2025. Front Oncol. 2025. PMID: 40129920 Free PMC article. Review.
-
Bridging the tumor microenvironment: the pivotal role of cancer-associated fibroblasts in tumor cachexia development.Mol Cancer. 2025 Jul 14;24(1):194. doi: 10.1186/s12943-025-02379-7. Mol Cancer. 2025. PMID: 40660208 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
- 82071970/National Natural Science Foundation of China
- 82272123/National Natural Science Foundation of China
- 81971775/National Natural Science Foundation of China
- 2022YFE0111700/Key Technologies Research and Development Program
- 2023AFA109/Science Fund for Distinguished Young Scholars of Hubei Province
LinkOut - more resources
Full Text Sources
Medical